nodes	percent_of_prediction	percent_of_DWPC	metapath
Mestranol—Estrogen Receptor Agonists—Ethinyl Estradiol—prostate cancer	0.138	0.397	CiPCiCtD
Mestranol—Estrogen Receptor Agonists—Estradiol—prostate cancer	0.105	0.301	CiPCiCtD
Mestranol—Estrogen Receptor Agonists—Conjugated Estrogens—prostate cancer	0.105	0.301	CiPCiCtD
Mestranol—Estramustine—prostate cancer	0.0725	0.271	CrCtD
Mestranol—ESR1—prostate cancer	0.0694	1	CbGaD
Mestranol—Estrone—prostate cancer	0.0576	0.216	CrCtD
Mestranol—Conjugated Estrogens—prostate cancer	0.0507	0.19	CrCtD
Mestranol—Estradiol—prostate cancer	0.0436	0.163	CrCtD
Mestranol—Ethinyl Estradiol—prostate cancer	0.0426	0.16	CrCtD
Mestranol—ESR1—Estramustine—prostate cancer	0.0337	0.274	CbGbCtD
Mestranol—ESR1—Estrone—prostate cancer	0.0217	0.176	CbGbCtD
Mestranol—ESR1—Ethinyl Estradiol—prostate cancer	0.0193	0.157	CbGbCtD
Mestranol—ESR1—Conjugated Estrogens—prostate cancer	0.0142	0.115	CbGbCtD
Mestranol—ESR1—Estradiol—prostate cancer	0.0125	0.101	CbGbCtD
Mestranol—Estriol—Estramustine—prostate cancer	0.00715	0.0404	CrCrCtD
Mestranol—CYP2C9—Nilutamide—prostate cancer	0.0064	0.052	CbGbCtD
Mestranol—CYP2C9—Bicalutamide—prostate cancer	0.0064	0.052	CbGbCtD
Mestranol—Conjugated Estrogens—Estramustine—prostate cancer	0.00609	0.0344	CrCrCtD
Mestranol—Estropipate—Estramustine—prostate cancer	0.00609	0.0344	CrCrCtD
Mestranol—Estriol—Estrone—prostate cancer	0.00568	0.0321	CrCrCtD
Mestranol—Estramustine—Estrone—prostate cancer	0.00568	0.0321	CrCrCtD
Mestranol—Estrone—Estradiol valerate/Dienogest—prostate cancer	0.00531	0.03	CrCrCtD
Mestranol—Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.00531	0.03	CrCrCtD
Mestranol—Ethinyl Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.00505	0.0285	CrCrCtD
Mestranol—Estriol—Conjugated Estrogens—prostate cancer	0.005	0.0282	CrCrCtD
Mestranol—Estramustine—Conjugated Estrogens—prostate cancer	0.005	0.0282	CrCrCtD
Mestranol—Conjugated Estrogens—Estrone—prostate cancer	0.00484	0.0273	CrCrCtD
Mestranol—Estropipate—Estrone—prostate cancer	0.00484	0.0273	CrCrCtD
Mestranol—Estrone—Estramustine—prostate cancer	0.00451	0.0255	CrCrCtD
Mestranol—Estradiol—Estramustine—prostate cancer	0.00451	0.0255	CrCrCtD
Mestranol—Quinestrol—Estramustine—prostate cancer	0.00451	0.0255	CrCrCtD
Mestranol—Estramustine—Estradiol—prostate cancer	0.0043	0.0243	CrCrCtD
Mestranol—Estriol—Estradiol—prostate cancer	0.0043	0.0243	CrCrCtD
Mestranol—Ethinyl Estradiol—Estramustine—prostate cancer	0.0043	0.0243	CrCrCtD
Mestranol—Estropipate—Conjugated Estrogens—prostate cancer	0.00426	0.024	CrCrCtD
Mestranol—Estramustine—Ethinyl Estradiol—prostate cancer	0.0042	0.0237	CrCrCtD
Mestranol—Estriol—Ethinyl Estradiol—prostate cancer	0.0042	0.0237	CrCrCtD
Mestranol—CYP2C9—Estrone—prostate cancer	0.00383	0.0311	CbGbCtD
Mestranol—Conjugated Estrogens—Estradiol—prostate cancer	0.00367	0.0207	CrCrCtD
Mestranol—Estropipate—Estradiol—prostate cancer	0.00367	0.0207	CrCrCtD
Mestranol—Quinestrol—Estrone—prostate cancer	0.00358	0.0202	CrCrCtD
Mestranol—Estradiol—Estrone—prostate cancer	0.00358	0.0202	CrCrCtD
Mestranol—Desogestrel—Ethinyl Estradiol—prostate cancer	0.00358	0.0202	CrCrCtD
Mestranol—Conjugated Estrogens—Ethinyl Estradiol—prostate cancer	0.00358	0.0202	CrCrCtD
Mestranol—Estropipate—Ethinyl Estradiol—prostate cancer	0.00358	0.0202	CrCrCtD
Mestranol—Ethinyl Estradiol—Estrone—prostate cancer	0.00341	0.0193	CrCrCtD
Mestranol—Estradiol—Conjugated Estrogens—prostate cancer	0.00316	0.0178	CrCrCtD
Mestranol—Estrone—Conjugated Estrogens—prostate cancer	0.00316	0.0178	CrCrCtD
Mestranol—Quinestrol—Conjugated Estrogens—prostate cancer	0.00316	0.0178	CrCrCtD
Mestranol—Ethinyl Estradiol—Conjugated Estrogens—prostate cancer	0.00301	0.017	CrCrCtD
Mestranol—Etonogestrel—Ethinyl Estradiol—prostate cancer	0.00295	0.0167	CrCrCtD
Mestranol—CYP2C9—Capecitabine—prostate cancer	0.00291	0.0236	CbGbCtD
Mestranol—Norelgestromin—Ethinyl Estradiol—prostate cancer	0.00279	0.0158	CrCrCtD
Mestranol—Quinestrol—Estradiol—prostate cancer	0.00272	0.0153	CrCrCtD
Mestranol—Estrone—Estradiol—prostate cancer	0.00272	0.0153	CrCrCtD
Mestranol—Estrone—Ethinyl Estradiol—prostate cancer	0.00265	0.015	CrCrCtD
Mestranol—Estradiol—Ethinyl Estradiol—prostate cancer	0.00265	0.015	CrCrCtD
Mestranol—Quinestrol—Ethinyl Estradiol—prostate cancer	0.00265	0.015	CrCrCtD
Mestranol—Ethinyl Estradiol—Estradiol—prostate cancer	0.00259	0.0146	CrCrCtD
Mestranol—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.00231	0.013	CrCrCtD
Mestranol—CYP2C9—Estradiol—prostate cancer	0.0022	0.0179	CbGbCtD
Mestranol—Danazol—Ethinyl Estradiol—prostate cancer	0.00213	0.012	CrCrCtD
Mestranol—Norethindrone—Ethinyl Estradiol—prostate cancer	0.00186	0.0105	CrCrCtD
Mestranol—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.00152	0.0086	CrCrCtD
Mestranol—Danazol—Prednisone—prostate cancer	0.000749	0.00423	CrCrCtD
Mestranol—Methyltestosterone—Prednisone—prostate cancer	0.000535	0.00302	CrCrCtD
Mestranol—Dextromethorphan—PGRMC1—prostate cancer	0.000102	0.079	CrCbGaD
Mestranol—Levonorgestrel—SRD5A1—prostate cancer	6.53e-05	0.0504	CrCbGaD
Mestranol—Ethinyl Estradiol—AOX1—prostate cancer	5.03e-05	0.0389	CrCbGaD
Mestranol—Desogestrel—SHBG—prostate cancer	3.86e-05	0.0298	CrCbGaD
Mestranol—Estriol—ESR2—prostate cancer	3.74e-05	0.0289	CrCbGaD
Mestranol—Quinestrol—ESR1—prostate cancer	3.48e-05	0.0269	CrCbGaD
Mestranol—Estramustine—ESR2—prostate cancer	3.47e-05	0.0269	CrCbGaD
Mestranol—Estriol—SHBG—prostate cancer	3.41e-05	0.0263	CrCbGaD
Mestranol—Estradiol—AOX1—prostate cancer	3.32e-05	0.0257	CrCbGaD
Mestranol—Etonogestrel—SHBG—prostate cancer	3.12e-05	0.0241	CrCbGaD
Mestranol—Estropipate—ESR2—prostate cancer	2.86e-05	0.0221	CrCbGaD
Mestranol—Estropipate—SHBG—prostate cancer	2.61e-05	0.0201	CrCbGaD
Mestranol—Desogestrel—ESR1—prostate cancer	2.61e-05	0.0201	CrCbGaD
Mestranol—Estropipate—SLC22A1—prostate cancer	2.57e-05	0.0199	CrCbGaD
Mestranol—Estriol—ESR1—prostate cancer	2.3e-05	0.0178	CrCbGaD
Mestranol—Levonorgestrel—SHBG—prostate cancer	2.21e-05	0.0171	CrCbGaD
Mestranol—Estramustine—ESR1—prostate cancer	2.14e-05	0.0165	CrCbGaD
Mestranol—Etonogestrel—ESR1—prostate cancer	2.11e-05	0.0163	CrCbGaD
Mestranol—Ethinyl Estradiol—ESR2—prostate cancer	2.04e-05	0.0158	CrCbGaD
Mestranol—Danazol—SHBG—prostate cancer	2.01e-05	0.0156	CrCbGaD
Mestranol—Levonorgestrel—AR—prostate cancer	1.94e-05	0.015	CrCbGaD
Mestranol—Conjugated Estrogens—COMT—prostate cancer	1.91e-05	0.0148	CrCbGaD
Mestranol—Ethinyl Estradiol—SHBG—prostate cancer	1.86e-05	0.0144	CrCbGaD
Mestranol—Norethindrone—SHBG—prostate cancer	1.79e-05	0.0138	CrCbGaD
Mestranol—Conjugated Estrogens—ESR2—prostate cancer	1.78e-05	0.0138	CrCbGaD
Mestranol—Estrone—ESR2—prostate cancer	1.78e-05	0.0137	CrCbGaD
Mestranol—Danazol—AR—prostate cancer	1.76e-05	0.0136	CrCbGaD
Mestranol—Estropipate—ESR1—prostate cancer	1.76e-05	0.0136	CrCbGaD
Mestranol—Methyltestosterone—SHBG—prostate cancer	1.7e-05	0.0131	CrCbGaD
Mestranol—Estradiol—SLC22A3—prostate cancer	1.69e-05	0.0131	CrCbGaD
Mestranol—Estrone—SHBG—prostate cancer	1.62e-05	0.0125	CrCbGaD
Mestranol—Estrone—CYP1B1—prostate cancer	1.62e-05	0.0125	CrCbGaD
Mestranol—Levonorgestrel—CYP19A1—prostate cancer	1.62e-05	0.0125	CrCbGaD
Mestranol—Levonorgestrel—ESR1—prostate cancer	1.49e-05	0.0115	CrCbGaD
Mestranol—Methyltestosterone—AR—prostate cancer	1.49e-05	0.0115	CrCbGaD
Mestranol—Danazol—CYP19A1—prostate cancer	1.48e-05	0.0114	CrCbGaD
Mestranol—Norethindrone—CYP3A5—prostate cancer	1.43e-05	0.011	CrCbGaD
Mestranol—Danazol—ESR1—prostate cancer	1.36e-05	0.0105	CrCbGaD
Mestranol—Estradiol—ESR2—prostate cancer	1.35e-05	0.0104	CrCbGaD
Mestranol—Dextromethorphan—CYP3A5—prostate cancer	1.35e-05	0.0104	CrCbGaD
Mestranol—Estrone—CYP3A5—prostate cancer	1.29e-05	0.00998	CrCbGaD
Mestranol—Ethinyl Estradiol—ESR1—prostate cancer	1.26e-05	0.00972	CrCbGaD
Mestranol—Methyltestosterone—CYP19A1—prostate cancer	1.25e-05	0.00965	CrCbGaD
Mestranol—Estradiol—SHBG—prostate cancer	1.23e-05	0.0095	CrCbGaD
Mestranol—Estradiol—CYP1B1—prostate cancer	1.23e-05	0.0095	CrCbGaD
Mestranol—Estradiol—SLC22A1—prostate cancer	1.21e-05	0.00938	CrCbGaD
Mestranol—Conjugated Estrogens—ESR1—prostate cancer	1.1e-05	0.00849	CrCbGaD
Mestranol—Estrone—ESR1—prostate cancer	1.1e-05	0.00847	CrCbGaD
Mestranol—Estramustine—CYP3A4—prostate cancer	1.09e-05	0.00844	CrCbGaD
Mestranol—Estradiol—AR—prostate cancer	1.08e-05	0.00833	CrCbGaD
Mestranol—Etonogestrel—CYP3A4—prostate cancer	1.08e-05	0.00832	CrCbGaD
Mestranol—Estradiol—CYP3A5—prostate cancer	9.79e-06	0.00757	CrCbGaD
Mestranol—Norethindrone—CYP2C19—prostate cancer	9.71e-06	0.0075	CrCbGaD
Mestranol—Dextromethorphan—CYP2E1—prostate cancer	9.25e-06	0.00715	CrCbGaD
Mestranol—Dextromethorphan—CYP2C19—prostate cancer	9.16e-06	0.00708	CrCbGaD
Mestranol—Estropipate—CYP3A4—prostate cancer	8.99e-06	0.00694	CrCbGaD
Mestranol—Estrone—CYP2E1—prostate cancer	8.88e-06	0.00686	CrCbGaD
Mestranol—Estrone—CYP1A1—prostate cancer	8.76e-06	0.00677	CrCbGaD
Mestranol—Estradiol—ESR1—prostate cancer	8.31e-06	0.00642	CrCbGaD
Mestranol—Levonorgestrel—CYP3A4—prostate cancer	7.62e-06	0.00589	CrCbGaD
Mestranol—Danazol—CYP3A4—prostate cancer	6.94e-06	0.00536	CrCbGaD
Mestranol—Estradiol—CYP2C19—prostate cancer	6.66e-06	0.00515	CrCbGaD
Mestranol—Estradiol—CYP1A1—prostate cancer	6.64e-06	0.00513	CrCbGaD
Mestranol—Ethinyl Estradiol—CYP3A4—prostate cancer	6.42e-06	0.00496	CrCbGaD
Mestranol—Norethindrone—CYP3A4—prostate cancer	6.17e-06	0.00477	CrCbGaD
Mestranol—Methyltestosterone—CYP3A4—prostate cancer	5.86e-06	0.00453	CrCbGaD
Mestranol—Dextromethorphan—CYP3A4—prostate cancer	5.83e-06	0.0045	CrCbGaD
Mestranol—Conjugated Estrogens—CYP3A4—prostate cancer	5.61e-06	0.00433	CrCbGaD
Mestranol—Estrone—CYP3A4—prostate cancer	5.59e-06	0.00432	CrCbGaD
Mestranol—CYP2C9—Metabolism—CBR1—prostate cancer	5e-06	0.000331	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CSAD—prostate cancer	5e-06	0.000331	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—TST—prostate cancer	5e-06	0.000331	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GRHL1—prostate cancer	5e-06	0.000331	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ADI1—prostate cancer	5e-06	0.000331	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	4.98e-06	0.00033	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	4.97e-06	0.000329	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—TP53—prostate cancer	4.94e-06	0.000327	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	4.89e-06	0.000324	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	4.87e-06	0.000323	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	4.79e-06	0.000318	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CKMT2—prostate cancer	4.65e-06	0.000308	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GRHPR—prostate cancer	4.65e-06	0.000308	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—UGT2B15—prostate cancer	4.65e-06	0.000308	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—UGT2B17—prostate cancer	4.65e-06	0.000308	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	4.6e-06	0.000305	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	4.54e-06	0.000301	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PENK—prostate cancer	4.52e-06	0.000299	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—IL6—prostate cancer	4.5e-06	0.000298	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—MED12—prostate cancer	4.47e-06	0.000296	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—RPS19—prostate cancer	4.4e-06	0.000292	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTM3—prostate cancer	4.37e-06	0.00029	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—MBTPS1—prostate cancer	4.37e-06	0.00029	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—RFK—prostate cancer	4.37e-06	0.00029	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—AOX1—prostate cancer	4.37e-06	0.00029	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NAGLU—prostate cancer	4.37e-06	0.00029	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SULT2B1—prostate cancer	4.37e-06	0.00029	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PGAM2—prostate cancer	4.37e-06	0.00029	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—GHR—prostate cancer	4.31e-06	0.000285	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	4.27e-06	0.000283	CbGpPWpGaD
Mestranol—Estradiol—CYP3A4—prostate cancer	4.24e-06	0.00328	CrCbGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	4.23e-06	0.00028	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—DNMT1—prostate cancer	4.21e-06	0.000279	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—CREBBP—prostate cancer	4.17e-06	0.000276	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—AKT1—prostate cancer	4.17e-06	0.000276	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—AKT1—prostate cancer	4.15e-06	0.000275	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP3A43—prostate cancer	4.14e-06	0.000275	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—AMACR—prostate cancer	4.14e-06	0.000275	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NAT1—prostate cancer	4.14e-06	0.000275	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SRD5A2—prostate cancer	4.14e-06	0.000275	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—DEGS1—prostate cancer	4.14e-06	0.000275	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—NCOA2—prostate cancer	4.13e-06	0.000274	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NRP1—prostate cancer	4.13e-06	0.000274	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	4.09e-06	0.000271	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—EZH2—prostate cancer	4.08e-06	0.00027	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	4.07e-06	0.00027	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	4.05e-06	0.000268	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—PARP1—prostate cancer	3.99e-06	0.000264	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—HSD17B1—prostate cancer	3.95e-06	0.000262	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	3.95e-06	0.000262	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—SERPINE1—prostate cancer	3.91e-06	0.000259	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—GNRH1—prostate cancer	3.84e-06	0.000254	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—VIP—prostate cancer	3.84e-06	0.000254	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	3.8e-06	0.000252	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	3.78e-06	0.00025	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—ESR2—prostate cancer	3.78e-06	0.00025	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—HSPA1A—prostate cancer	3.78e-06	0.00025	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	3.74e-06	0.000248	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—LPAR1—prostate cancer	3.72e-06	0.000246	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—GRP—prostate cancer	3.72e-06	0.000246	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PLCB2—prostate cancer	3.68e-06	0.000244	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—LRP2—prostate cancer	3.68e-06	0.000244	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—P4HB—prostate cancer	3.61e-06	0.000239	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CX3CL1—prostate cancer	3.61e-06	0.000239	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	3.56e-06	0.000236	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—HIST1H2BG—prostate cancer	3.54e-06	0.000235	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—HPGD—prostate cancer	3.52e-06	0.000233	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—B4GALT4—prostate cancer	3.52e-06	0.000233	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—GRB7—prostate cancer	3.51e-06	0.000233	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PDE4D—prostate cancer	3.51e-06	0.000233	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—NCOA1—prostate cancer	3.48e-06	0.000231	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	3.46e-06	0.000229	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—HIST1H4H—prostate cancer	3.42e-06	0.000227	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—GNG5—prostate cancer	3.34e-06	0.000221	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—AR—prostate cancer	3.34e-06	0.000221	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—TNFRSF21—prostate cancer	3.31e-06	0.000219	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—RXRA—prostate cancer	3.31e-06	0.000219	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP7B1—prostate cancer	3.22e-06	0.000213	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—MTAP—prostate cancer	3.22e-06	0.000213	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	3.15e-06	0.000209	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SULT1E1—prostate cancer	3.14e-06	0.000208	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SRD5A1—prostate cancer	3.14e-06	0.000208	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	3.05e-06	0.000202	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—SIRT1—prostate cancer	3.04e-06	0.000202	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	3e-06	0.000199	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—VDR—prostate cancer	3e-06	0.000199	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ACSL4—prostate cancer	3e-06	0.000198	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—HSD17B3—prostate cancer	3e-06	0.000198	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.96e-06	0.000196	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—TGFBR1—prostate cancer	2.91e-06	0.000193	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PTHLH—prostate cancer	2.91e-06	0.000193	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PHGDH—prostate cancer	2.87e-06	0.00019	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—UMPS—prostate cancer	2.87e-06	0.00019	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ARG2—prostate cancer	2.87e-06	0.00019	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—AKR1C3—prostate cancer	2.86e-06	0.00019	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.86e-06	0.000189	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PRKACB—prostate cancer	2.85e-06	0.000189	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—LDHB—prostate cancer	2.82e-06	0.000187	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—THBS1—prostate cancer	2.78e-06	0.000184	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PPP3CA—prostate cancer	2.78e-06	0.000184	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP3A5—prostate cancer	2.76e-06	0.000183	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—ERCC2—prostate cancer	2.74e-06	0.000182	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—ANXA1—prostate cancer	2.74e-06	0.000181	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—NR3C1—prostate cancer	2.7e-06	0.000179	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PRKCZ—prostate cancer	2.69e-06	0.000178	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PDHA1—prostate cancer	2.67e-06	0.000177	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—TCN2—prostate cancer	2.67e-06	0.000177	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—UCP3—prostate cancer	2.67e-06	0.000177	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTA3—prostate cancer	2.67e-06	0.000177	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—FGFR4—prostate cancer	2.59e-06	0.000172	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PARP1—prostate cancer	2.59e-06	0.000172	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CALCA—prostate cancer	2.56e-06	0.00017	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SLC22A3—prostate cancer	2.55e-06	0.000169	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—HSD3B1—prostate cancer	2.55e-06	0.000169	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—PPARA—prostate cancer	2.53e-06	0.000168	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CXCL12—prostate cancer	2.5e-06	0.000166	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—MYC—prostate cancer	2.48e-06	0.000164	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.47e-06	0.000164	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTA4—prostate cancer	2.44e-06	0.000162	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—TBXAS1—prostate cancer	2.44e-06	0.000162	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.39e-06	0.000158	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTA2—prostate cancer	2.38e-06	0.000158	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CASP9—prostate cancer	2.36e-06	0.000156	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ABCG5—prostate cancer	2.35e-06	0.000156	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SULT1A1—prostate cancer	2.35e-06	0.000156	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTA1—prostate cancer	2.3e-06	0.000152	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PRKCQ—prostate cancer	2.28e-06	0.000151	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NGFR—prostate cancer	2.28e-06	0.000151	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NAT2—prostate cancer	2.27e-06	0.00015	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—HSD3B2—prostate cancer	2.27e-06	0.00015	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTO1—prostate cancer	2.27e-06	0.00015	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MAP3K7—prostate cancer	2.26e-06	0.00015	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.18e-06	0.000145	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PLCB2—prostate cancer	2.18e-06	0.000144	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—LRP2—prostate cancer	2.18e-06	0.000144	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP2C18—prostate cancer	2.18e-06	0.000144	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—FGF10—prostate cancer	2.17e-06	0.000144	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—ADRB2—prostate cancer	2.15e-06	0.000142	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—P4HB—prostate cancer	2.13e-06	0.000141	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—VAV3—prostate cancer	2.09e-06	0.000139	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SLC22A1—prostate cancer	2.08e-06	0.000138	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—TGFBR2—prostate cancer	2.06e-06	0.000137	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.05e-06	0.000136	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—ITPR1—prostate cancer	2.03e-06	0.000135	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SULT2A1—prostate cancer	2.02e-06	0.000134	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—CREBBP—prostate cancer	2.01e-06	0.000133	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—MED12—prostate cancer	1.99e-06	0.000132	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GNG5—prostate cancer	1.97e-06	0.000131	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—IGF1R—prostate cancer	1.94e-06	0.000129	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NCOA3—prostate cancer	1.9e-06	0.000126	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—SERPINE1—prostate cancer	1.88e-06	0.000125	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.87e-06	0.000124	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—LPL—prostate cancer	1.86e-06	0.000123	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PDGFRB—prostate cancer	1.85e-06	0.000122	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—HPGDS—prostate cancer	1.81e-06	0.00012	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP2C19—prostate cancer	1.8e-06	0.000119	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—ITGB3—prostate cancer	1.8e-06	0.000119	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ACHE—prostate cancer	1.76e-06	0.000117	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTT1—prostate cancer	1.76e-06	0.000117	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—ERBB3—prostate cancer	1.74e-06	0.000116	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—FGFR2—prostate cancer	1.74e-06	0.000115	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP2A6—prostate cancer	1.74e-06	0.000115	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.73e-06	0.000115	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—AKR1C3—prostate cancer	1.69e-06	0.000112	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PRKACB—prostate cancer	1.68e-06	0.000112	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—TERT—prostate cancer	1.67e-06	0.000111	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP17A1—prostate cancer	1.67e-06	0.00011	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.64e-06	0.000109	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—HIF1A—prostate cancer	1.6e-06	0.000106	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NCOA2—prostate cancer	1.59e-06	0.000105	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—LEP—prostate cancer	1.56e-06	0.000103	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CAV1—prostate cancer	1.55e-06	0.000102	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—KDR—prostate cancer	1.53e-06	0.000101	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SLC5A5—prostate cancer	1.51e-06	0.0001	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.48e-06	9.8e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NQO1—prostate cancer	1.46e-06	9.69e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—BAD—prostate cancer	1.45e-06	9.64e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—TH—prostate cancer	1.44e-06	9.55e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.43e-06	9.49e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.43e-06	9.45e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.42e-06	9.4e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—APC—prostate cancer	1.41e-06	9.33e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PIK3CG—prostate cancer	1.41e-06	9.33e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.4e-06	9.29e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—EGF—prostate cancer	1.39e-06	9.22e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—IRS1—prostate cancer	1.39e-06	9.22e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GGT1—prostate cancer	1.36e-06	9e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—GSK3B—prostate cancer	1.35e-06	8.95e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NCOA1—prostate cancer	1.34e-06	8.86e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—INS—prostate cancer	1.33e-06	8.83e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.32e-06	8.74e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CREBBP—prostate cancer	1.31e-06	8.65e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—IGF1—prostate cancer	1.29e-06	8.54e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—RXRA—prostate cancer	1.27e-06	8.43e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MAP2K1—prostate cancer	1.25e-06	8.26e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PIK3CD—prostate cancer	1.24e-06	8.2e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.24e-06	8.2e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—COMT—prostate cancer	1.23e-06	8.12e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—SERPINE1—prostate cancer	1.22e-06	8.11e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTP1—prostate cancer	1.22e-06	8.08e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ITPR1—prostate cancer	1.2e-06	7.95e-05	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—MYC—prostate cancer	1.19e-06	7.9e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—FGF2—prostate cancer	1.19e-06	7.85e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.18e-06	7.82e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NOS3—prostate cancer	1.17e-06	7.75e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—JAK2—prostate cancer	1.14e-06	7.53e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—TYMS—prostate cancer	1.13e-06	7.52e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTM1—prostate cancer	1.12e-06	7.43e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MDM2—prostate cancer	1.11e-06	7.35e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—LPL—prostate cancer	1.1e-06	7.29e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—ERBB2—prostate cancer	1.09e-06	7.25e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PIK3CB—prostate cancer	1.08e-06	7.15e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.06e-06	7.04e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ERCC2—prostate cancer	1.05e-06	6.98e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CXCL8—prostate cancer	1.04e-06	6.87e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CDKN1B—prostate cancer	1.01e-06	6.71e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CASP3—prostate cancer	9.93e-07	6.58e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—IL2—prostate cancer	9.91e-07	6.57e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—MTHFR—prostate cancer	9.91e-07	6.57e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PPARA—prostate cancer	9.72e-07	6.44e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CCND1—prostate cancer	9.66e-07	6.4e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CTNNB1—prostate cancer	9.57e-07	6.34e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MMP9—prostate cancer	9.38e-07	6.22e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CDKN1A—prostate cancer	9.35e-07	6.19e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PTEN—prostate cancer	9.33e-07	6.18e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CAV1—prostate cancer	9.14e-07	6.06e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—EP300—prostate cancer	8.89e-07	5.89e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.73e-07	5.79e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—SRC—prostate cancer	8.65e-07	5.73e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—VEGFA—prostate cancer	8.42e-07	5.58e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—STAT3—prostate cancer	8.34e-07	5.53e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PIK3CG—prostate cancer	8.32e-07	5.52e-05	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—AKT1—prostate cancer	8.27e-07	5.48e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—INS—prostate cancer	7.88e-07	5.22e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MYC—prostate cancer	7.75e-07	5.13e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—TGFB1—prostate cancer	7.73e-07	5.12e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CREBBP—prostate cancer	7.72e-07	5.11e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—EGFR—prostate cancer	7.58e-07	5.02e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PIK3CD—prostate cancer	7.32e-07	4.85e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—KRAS—prostate cancer	7.16e-07	4.74e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NOS3—prostate cancer	6.91e-07	4.58e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PIK3CA—prostate cancer	6.58e-07	4.36e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PIK3CB—prostate cancer	6.38e-07	4.23e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—TP53—prostate cancer	6.36e-07	4.22e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PTGS2—prostate cancer	6.32e-07	4.19e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—IL6—prostate cancer	5.83e-07	3.86e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PTEN—prostate cancer	5.51e-07	3.65e-05	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—AKT1—prostate cancer	5.37e-07	3.56e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—EP300—prostate cancer	5.26e-07	3.48e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.89e-07	2.58e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—AKT1—prostate cancer	3.18e-07	2.1e-05	CbGpPWpGaD
